3358 Real-world evaluation of outcomes in relapsed/refractory multiple myeloma patients that are triple-class exposed after receiving 2 or more prior lines of therapy

2023
Radwanski K, Yu J, Pierce K, Talati C, Stricker S, Jiao S, Bueno O
Read more